Wednesday, June 4, 2008

Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients

Posted by kucinx at 7:06 PM

No comments:

Loading....

Post a Comment

Subscribe to: Post Comments (Atom)